Author Page for Pekka Kolehmainen

Actions:

View:
Selected
Original List
All Versions Hide All Versions
All Abstracts Hide All Abstracts

(Rank)

Long-Term Neutralization Capacity of Vaccine and Breakthrough Infection Induced Sars-Cov-2 Specific Antibodies Against Omicron Variants Ba.2, Xbb.1.5, and Jn.1

Number of pages: 25 Posted: 14 Aug 2025

Arttu Reinholm, Hira Khan, Terhi Laakso, Sari Maljanen, Pinja Jalkanen, Marianne Gunell, Teemu Kallonen, Pamela Österlund, Olli Ritvos, Arttu Nousiainen, Hanni Häkkinen, Sari Pakkanen, Hanna Välimaa, Anu Kantele, Johanna Lempainen, Ilkka Julkunen, Pekka Kolehmainen and Laura Kakkola

University of Turku, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Turku University Hospital - Department of Clinical Microbiology, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Turku - Department of Pediatrics, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN

Downloads 55 (1,020,567)

Pekka Kolehmainen

affiliation not provided to SSRN

1

55

0

Scholarly Papers (1)

Long-Term Neutralization Capacity of Vaccine and Breakthrough Infection Induced Sars-Cov-2 Specific Antibodies Against Omicron Variants Ba.2, Xbb.1.5, and Jn.1

Abstract: